1) serous epithelial ovarian carcinoma
浆液性上皮性卵巢癌
1.
To reveal chemokines mediating the celiac metastasis of epithelial ovarian carcinoma by way of investigating the chemokine receptor expressions in serous epithelial ovarian carcinoma cell lines and tissues, and the corresponding ligand expressions in membrana abdominis.
本研究通过分析浆液性上皮性卵巢癌细胞系和组织趋化因子受体的表达，及腹膜间皮细胞相应配体的表达，以揭示趋化因子介导上皮性卵巢癌腹腔内转移机制。
2) Ovarian serous adenocarcinoma
卵巢浆液性腺癌
1.
ER, PR, nm23-Hl, E-cadherin, AKT and pAKT expressions were measured by using of immunohistochemical staining in ovarian clear cell adenocarcinoma, ovarian serous adenocarcinoma, ovarian borderline and benign serous cystadenoma paraffin-embedded specimen.
卵巢透明细胞癌和卵巢浆液性腺癌为恶性程度较高、易转移、复发率高、预后差的两种组织学类型。
3) ovarian serous carcinoma
卵巢浆液性癌
1.
Analysis in the number of CD4~+CD25~+ and CD8~+ T lymphocytes in ovarian serous carcinoma;
癌灶CD4~+CD25~+和CD8~+ T细胞亚群与卵巢浆液性癌患者生存期相关
2.
Recently, following the further understanding of clinical pathomorphology characteristic about ovarian serous carcinoma and the development of molecular genetics, we have a new recognition about the pathogenesis and pathomorphology characteristic of ovarian serous carcinoma, and propose a dualistic theory model for ovarian serous carcinogenesis.
近年来,随着对卵巢浆液性癌的临床病理形态学特征的的深入了解和分子遗传学的发展,有关卵巢浆液性癌的发生机制和临床病理形态特征有了新的认识,并初步建立了卵巢低级别浆液性癌与高级别浆液性癌存在不同的发病机制的二元论模型:低分级浆液性癌通过良性-交界性-恶性过程逐步发展形成,而高分级浆液性癌是从正常卵巢表面上皮、包涵囊肿或输卵管上皮直接发展形成。
4) serous ovarian cancer
浆液性卵巢癌
1.
One of serous ovarian cancer is epithelial ovarian cancer the most common histological type, accounting for 50% of malignant ovarian tumors.
其中浆液性卵巢癌是卵巢上皮性癌中最常见的组织学类型,占卵巢恶性肿瘤的50%。
5) Epithelial ovarian cancer
卵巢上皮性癌
1.
Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer;
MMP-2和TIMP-2基因启动子区多态性与卵巢上皮性癌关系的研究
2.
WWOX mRNA expression in epithelial ovarian cancer and its clinical significance;
WWOX mRNA在卵巢上皮性癌组织中的表达及临床意义
3.
Homozygous deletion of p15、p16 genes and its co-deletion of p15/16 genes in serum DNA of the epithelial ovarian cancer;
卵巢上皮性癌血清DNA中p15、p16基因纯合性丢失及其共丢失的研究
6) Epithelial ovarian cancer
上皮性卵巢癌
1.
Expression of P53 and Survivin protein in epithelial ovarian cancer tissue;
上皮性卵巢癌组织中P53和Survivin蛋白的表达
2.
Relationship of cyclooxygenase-2 expression and chemotherapy resistance in epithelial ovarian cancer patients;
上皮性卵巢癌组织中环氧化酶-2的表达与化疗耐药的相关性研究
3.
The expression of lung resistance protein and c-erbB-2 in primary epithelial ovarian cancer and its clinical significance;
LRP与c-erbB-2在上皮性卵巢癌中的表达及临床意义
补充资料：卵巢混合性生殖细胞-性索间质性肿瘤
卵巢混合性生殖细胞-性索间质性肿瘤
本瘤1921年首次由Masson描述，直到1972年由Telerman首次命名为本瘤，并沿用至今，本瘤病因尚不明了。发生年龄自新生儿到67岁妇女均可发生，少数为男性。临床表现：患者为正常女性及男性外表，女性病人可有下腹包块，发生蒂扭转时有下腹痛，并有急腹症症状，可有内分泌紊乱，性早熟表现，男性有睾丸增大。染色体核型分析均正常。内分泌检查与临床表现符合，肿瘤为单侧，圆形或卵圆形。表面光滑，直径2.5～30cm，实性肿瘤内有囊性区。切面灰白、灰红或淡黄至淡褐色。镜下有梭形细胞及生殖细胞。治疗：视情况采取单纯手术，或手术加放疗及化疗。需长期随访。预后：单纯本病者良好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条